305 results
8-K
EX-99.1
HRTX
Heron Therapeutics Inc
12 Mar 24
Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
4:10pm
Months Ended
December 31,
Revenues:
(unaudited)
Net product sales
Cost of product sales
Gross profit
Operating expenses:
Research and development
General
8-K
EX-99.1
HRTX
Heron Therapeutics Inc
14 Nov 23
Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial Guidance
4:10pm
September 30,
(unaudited)
Revenues:
Net product sales
Cost of product sales
Gross profit
Operating expenses:
Research and development
General
424B3
qudergrnl03cglhcra93
5 Sep 23
Prospectus supplement
9:14pm
8-K
EX-99.1
8t3n857y
14 Aug 23
Heron Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Updates
4:11pm
8-K
EX-10.1
ekgwf 220lvdjx
24 Jul 23
Heron Therapeutics Announces $30 Million Private Placement Financing
9:12am
8-K
EX-99.2
wmdqhmt77e8 cct5b
24 Jul 23
Heron Therapeutics Announces $30 Million Private Placement Financing
9:12am
8-K
EX-99.1
e8i0zy zop
12 Jun 23
Heron Therapeutics Announces Appointment of William Forbes, Pharm.D. as Chief Development Officer
9:10am
8-K
EX-99.1
h8wpjlj
11 May 23
Net Product Sales for First Quarter of 2023 Grew 26% to $29.6 million, Compared to First Quarter Net Product Sales in 2022
4:06pm
8-K
EX-99.1
qsj1ot6omg8
8 Nov 22
Results of Operations and Financial Condition
4:10pm